Purple Biotech Ltd. (PPBT)
$1.33-7.64%Close
SELLCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $183,652
- Beta
- -0.53
- P/E (TTM)
- -0.01
- Short % float
- 13.88%
- Days to cover
- 1.0
- SI change
- -77.6%
- 1W
- -11.92%
- 1M
- -23.56%
- vs SPY 1W
- -13.08%
- vs SPY 1M
- -26.56%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PPBT?
- LOPJLB’s latest quantitative signal on Purple Biotech Ltd. (PPBT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PPBT in?
- Purple Biotech Ltd. (PPBT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Purple Biotech Ltd. (PPBT) do?
- Purple Biotech Ltd., a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor immune evasion and drug resistance. Its pipeline features two primary oncology assets: CM24: A monoclonal antibody designed to block carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1…